120 related articles for article (PubMed ID: 11872354)
1. Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
Cressey TR; Tilby MJ; Newell DR
Eur J Cancer; 2002 Mar; 38(4):586-93. PubMed ID: 11872354
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of telomerase activity by cisplatin in human testicular cancer cells.
Burger AM; Double JA; Newell DR
Eur J Cancer; 1997 Apr; 33(4):638-44. PubMed ID: 9274448
[TBL] [Abstract][Full Text] [Related]
3. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
4. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Zhang RG; Zhang RP; Wang XW; Xie H
Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
[TBL] [Abstract][Full Text] [Related]
5. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
Hill BT; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Bedford P
Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):75-83. PubMed ID: 2380098
[TBL] [Abstract][Full Text] [Related]
6. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines.
Walker MC; Povey S; Parrington JM; Riddle PN; Knuechel R; Masters JR
Eur J Cancer; 1990; 26(6):742-7. PubMed ID: 2144165
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line.
Mese H; Ueyama Y; Suzuki A; Nakayama S; Sasaki A; Hamakawa H; Matsumura T
Chemotherapy; 2001; 47(2):136-42. PubMed ID: 11173816
[TBL] [Abstract][Full Text] [Related]
9. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity.
Taverna P; Hansson J; Scanlon KJ; Hill BT
Carcinogenesis; 1994 Sep; 15(9):2053-6. PubMed ID: 7923602
[TBL] [Abstract][Full Text] [Related]
10. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
11. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
Sakin V; Eskiocak U; Kars MD; Iseri OD; Gunduz U
Exp Oncol; 2008 Sep; 30(3):202-5. PubMed ID: 18806742
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
Kondo Y; Komata T; Kondo S
Int J Oncol; 2001 Jun; 18(6):1287-92. PubMed ID: 11351264
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
Villa R; Folini M; Perego P; Supino R; Setti E; Daidone MG; Zunino F; Zaffaroni N
Int J Oncol; 2000 May; 16(5):995-1002. PubMed ID: 10762636
[TBL] [Abstract][Full Text] [Related]
14. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
15. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
[TBL] [Abstract][Full Text] [Related]
16. Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines.
Hill BT; Shellard SA; Fichtinger-Schepman AM; Schmoll HJ; Harstrick A
Anticancer Drugs; 1994 Jun; 5(3):321-8. PubMed ID: 7919457
[TBL] [Abstract][Full Text] [Related]
17. Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines.
Lian Z; Fujimoto J; Yokoyama Y; Niwa K; Tamaya T
Eur J Gynaecol Oncol; 2001; 22(5):347-9. PubMed ID: 11766737
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in human neuroblastoma cell lines correlates with clinical therapy.
Keshelava N; Seeger RC; Reynolds CP
Eur J Cancer; 1997 Oct; 33(12):2002-6. PubMed ID: 9516842
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of the unusual expression of cross resistance to cisplatin in a series of etoposide-selected resistant sublines of the SuSa testicular teratoma cell line.
Shellard SA; Hosking LK; Hill BT
Biochem Pharmacol; 1994 Mar; 47(5):775-9. PubMed ID: 8135853
[TBL] [Abstract][Full Text] [Related]
20. Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.
Maellaro E; Pacenti L; Del Bello B; Valentini MA; Mangiavacchi P; De Felice C; Rubegni P; Luzi P; Miracco C
Br J Dermatol; 2003 Jun; 148(6):1115-24. PubMed ID: 12828737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
